memantine hydrochloride and donepezil hydrochloride
- Product NDC
- 69680-185
- 11-digit product format
- 696800185
- Labeler code
- 69680
- Product ID
- 69680-185_ffe5cf41-299a-49e5-a9b8-c9048c4861fa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- memantine hydrochloride and donepezil hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Vitruvias Therapeutics, Inc.
- Application
- ANDA216901
- Marketing category
- ANDA
- Marketing start
- 2025-07-16
- Substance
- DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
- Active strength
- 10; 28 mg/1; mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- memantine hydrochloride and donepezil hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DONEPEZIL HYDROCHLORIDE | 10 mg/1 |
| MEMANTINE HYDROCHLORIDE | 28 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JY0WD0UA60, 3O2T2PJ89D |
| Rxcui | 1599803, 1599805 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69680-185-30 | memantine hydrochloride and donepezil hydrochloride | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 69680-185-30 | 69680018530 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-185-30) | 2025-07-16 | No | No | Current |